Cardiac disease remains the leading cause of mortality worldwide. Over the last 2 decades there have been tremendous advancements in the treatment of cardiac disease through minimally invasive techniques. The Cardiac Catheterization Laboratory of New York Presbyterian Hospital-Weill Cornell Medical Center is at the cutting edge of interventional cardiology participating in major NIH studies and the evaluation of novel clinical approaches. Our highly trained interventional cardiologists are specialized in the area of catheter-based methods to treat coronary artery disease, peripheral vascular disease, valvular heart disease and structural heart disease. Ranked 3rd in the Nation by U.S. News & World Report for 2017-18, the goals of the Cardiac Catheterization/Invasive Cardiology laboratory at Weill Cornell are to render the best quality, cutting-edge, minimally invasive interventional services for patients with cardiac disease. We also evaluate novel pre-clinical and clinical approaches in an effort to improve treatment options for our patients.
For patients with symptoms related to coronary artery disease, our physicians are able to perform both diagnostic and therapeutic procedures via small catheter inserted through a peripheral artery in the groin or wrist area. For patients with structural heart disease, including valve disorders, our physicians can utilize similar catheter based approaches to insert cardiac structural devices or new heart valves. These highly effective techniques obviate the need for open-heart surgery, consequently reducing the morbidity often associated with more invasive procedures.
Services For The Following Conditions Include:
- Obstructive coronary artery disease: balloon angioplasty, stent placement, rotational atherectomy, directional atherectomy, mechanical thrombectomy, and embolic protection
- Intravascular Ultrasound and FFR
- Stenotic valve disease: transcatheter aortic valve replacement (TAVR), balloon valvuloplasty
- Hypertrophic cardiomyopathy: alcohol septal ablation
- Peripheral artery disease, including obstructive carotid artery disease: balloon angioplasty, stent placement, and atherectomy
- Atrial septal defect and patent foramen ovale: non-surgical closure
Research Interests Include:
- Novel device evaluation in treatment of obstructive coronary disease, peripheral artery disease, and valvular disease
- Percutaneous treatment of valve disease
- Clinical investigation of novel atrial appendage closure devices
- Clinical investigation of novel access site closure devices
- Clinical investigation of novel, catheter-based approaches for the treatment of refractory hypertension
- Clinical evaluation of various antithrombotic and antiplatelet adjunct pharmacological agents in interventional procedures
- Pre-clinical evaluation of novel interventional devices in treatment of cardiovascular diseases
Forms For Referring Physicians:
To schedule Catheterization Lab Procedures:
If you are a referring physician and wish to schedule your patient for a Cardiac Catheterization Admission, please complete the CATH Lab Intake Form and fax to 212-746-8295. You may also contact our Intake office directly by calling 212-746-4644 and speak to one of our intake staff for more information or assistance.